SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048381
Filing Date
2024-04-25
Accepted
2024-04-25 16:30:11
Documents
9
Period of Report
2024-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_def14a_12312023.htm DEF 14A 1060741
2 GRAPHIC img95009157_0.jpg GRAPHIC 113127
3 GRAPHIC img95009157_1.jpg GRAPHIC 69802
4 GRAPHIC img95009157_2.jpg GRAPHIC 9790
5 GRAPHIC img95009157_3.jpg GRAPHIC 9790
6 GRAPHIC img95009157_4.jpg GRAPHIC 37254
7 GRAPHIC img95009157_5.jpg GRAPHIC 34920
8 GRAPHIC img95009157_6.jpg GRAPHIC 645304
9 GRAPHIC img95009157_7.jpg GRAPHIC 249067
  Complete submission text file 0000950170-24-048381.txt   2644818
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

IRS No.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40690 | Film No.: 24876838
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)